A comprehensive systematic review and meta-analysis published in Frontiers in Public Health has found that methicillin-resistant Staphylococcus aureus (MRSA) remains a major global health threat, with prevalence varying dramatically by region. The study, which analysed data from 100 studies published between 1998 and 2025, estimates the global pooled prevalence of MRSA at approximately 30% (95% CI: 0.18–0.44), though with very high heterogeneity between studies (I² = 98.3%).
Regional subgroup analyses revealed stark differences. The Middle East recorded the highest prevalence at roughly 50%, followed closely by Africa at approximately 45%. Asia and the Americas reported intermediate rates, while Europe had the lowest prevalence at around 12%. The authors, led by Nabil A. Nimer of Philadelphia University in Jordan, note that these disparities reflect differences in healthcare infrastructure, antibiotic use patterns, and surveillance capacity.
For university students and researchers in the Middle East, these findings underscore the importance of local infection control and antibiotic stewardship efforts. Students studying medicine, public health, or microbiology may find the data particularly relevant for understanding regional disease burdens and the need for coordinated surveillance.
According to the study, the molecular typing revealed widespread clonal complexes including ST8, ST22, ST239, and ST80, with local variations. The mecA gene, which encodes a modified penicillin-binding protein (PBP2a) with reduced affinity for beta-lactam antibiotics, was the primary mechanism of resistance. Multidrug resistance was frequently reported, especially in the Middle East and Africa, though vancomycin, teicoplanin, and linezolid remained active in nearly all studies that tested them.
The review highlights the Middle East as a region where multiple globally distributed lineages co-circulate alongside hospital-community hybrid strains. The authors point to the region's role as a hub for international travel, labour migration, and religious pilgrimage as potential factors facilitating the international dissemination of MRSA lineages. Countries with limited resources or inadequate infection-control programs report the highest MRSA burden, while those with robust antimicrobial stewardship programs, such as in Northern Europe, have successfully reduced rates.
The study employed a random-effects model to calculate pooled prevalence and conducted subgroup and heterogeneity analyses to identify regional differences and assess potential publication bias. The authors note that no prior protocol was registered in any public database, which is a limitation of the study design.
The findings are intended to inform international public health strategies and policy decisions for MRSA control, particularly in resource-limited settings. The authors call for coordinated global genomic surveillance, antibiotic stewardship, and infection-control measures to reduce the population-level impact of MRSA.